New genes discovered regulating brain metastases in lung cancer

August 8, 2017
Mohini Singh is a PhD candidate in biochemistry at the Michael G. DeGroote School of Medicine at McMaster University Credit: McMaster University

Research from McMaster University has identified new regulators of brain metastases in patients with lung cancer.

These regulators are the genes called SPOCK1 and TWIST2.

The discovery was made by researchers at the Stem Cell and Cancer Research Institute at McMaster University and was recently published online in the journalActa Neuropathologica.

"Brain metastases are a secondary brain tumour, which means they are caused by cancer cells that escape from primary tumours like lung, breast or melanoma, and travel to the brain," said Mohini Singh, the study's primary author and a PhD candidate in biochemistry at the Michael G. DeGroote School of Medicine at McMaster.

"We set out to find which genes can regulate the cells that initiate brain metastases, which we've termed brain metastasis initiating cells or BMICs. In other words, what are the genes that are sending the signal to these lung BMICs to leave the lung tumour, go into the blood stream, invade the blood-brain barrier and form a tumour in the brain."

The study used samples from patients with brain metastases. The samples were incubated to enrich for BMICs, then injected into the lungs, hearts and brains of mice. The subsequent development of brain metastases was studied by researchers.

"If you look at a set of , like we did in the paper, who develop brain metastases, they all have those two genes in their primary lung cancer," said Sheila Singh, the study's supervisor, associate professor at the Michael G. DeGroote School of Medicine, scientist with the Stem Cell and Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hospital.

"Patients who don't get don't have these genes in their primary lung cancer."

Brain metastases are the most common tumour in adults and are a leading cause of death in cancer patients.

"If you can identify the genes that cause metastases, then you can determine a predictive model and you can work towards blocking those with possible treatments," said Mohini Singh.

Explore further: Preventing the development of brain tumours

Related Stories

Preventing the development of brain tumours

August 3, 2017
Researchers from the University of Portsmouth's Brain Tumour Research Centre of Excellence have identified molecules which are responsible for metastatic lung cancer cells binding to blood vessels in the brain.

Mathematical modeling could help with personalized cancer care

July 12, 2017
A new study from the University of Southern California could pave the way for improving personalised lung cancer care and treatment.The research used mathematical modelling to examine if there was a link between the molecular ...

Estimating survival in patients with lung cancer, brain metastases

November 17, 2016
A new article published online by JAMA Oncology updates a tool to estimate survival in patients with lung cancer and brain metastases.

Genetic variants associated with colorectal brain metasases suscptibility and survival

February 1, 2016
Approx. 4,700 people in Austria fall ill with bowel cancer every year. One to two percent of the victims also sustain brain metastases during the latter stages of the illness. In a joint study with the University of Southern ...

Researchers discover how breast cancer spreads to the brain

March 2, 2017
Ninety percent of cancer deaths are from cancer spread. Breast cancer patients, for example, typically do not die because cancer returns in their breast, they die because it spreads to other parts of their body. The most ...

New treatment option for brain metastases associated with lung cancer

March 25, 2013
Lung cancer is the world's most common cause of death from cancer. In Austria, around 4,000 people develop this type of cancer every year. One particular problem is the development of brain metastases in association with ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

New study reveals breast cancer cells recycle their own ammonia waste as fuel

October 19, 2017
Breast cancer cells recycle ammonia, a waste byproduct of cell metabolism, and use it as a source of nitrogen to fuel tumor growth, report scientists from Harvard Medical School in the journal Science.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.